about
Mitochondrion: A Promising Target for Nanoparticle-Based Vaccine Delivery Systems.Recent Advances in Subunit Vaccine CarriersCancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers.Surface Modified Multifunctional and Stimuli Responsive Nanoparticles for Drug Targeting: Current Status and UsesCancer nanomedicine: from targeted delivery to combination therapyEngineering New Approaches to Cancer VaccinesCell delivery of therapeutic nanoparticlesNanomedicine and cancer immunotherapy: focus on indoleamine 2,3-dioxygenase inhibitorsThe era of bioengineering: how will this affect the next generation of cancer immunotherapy?In vitro performance of lipid-PLGA hybrid nanoparticles as an antigen delivery system: lipid composition mattersEvaluation of the levofloxacin release characters from a rabbit foldable capsular vitreous bodyThe combination of a low-dose chemotherapeutic agent, 5-fluorouracil, and an adenoviral tumor vaccine has a synergistic benefit on survival in a tumor model system.Protection of non-human primates against glanders with a gold nanoparticle glycoconjugate vaccine.A trifunctional dextran-based nanovaccine targets and activates murine dendritic cells, and induces potent cellular and humoral immune responses in vivo.Tumor immunotherapy using adenovirus vaccines in combination with intratumoral doses of CpG ODNPerorally active nanomicellar formulation of quercetin in the treatment of lung cancerPreparation and characterization of different liposomal formulations containing P5 HER2/neu-derived peptide and evaluation of their immunological responses and antitumor effects.Diaminosulfide based polymer microparticles as cancer vaccine delivery systems.Characterizing the antitumor response in mice treated with antigen-loaded polyanhydride microparticlesHigh-density sub-100-nm peptide-gold nanoparticle complexes improve vaccine presentation by dendritic cells in vitroViral-mimicking protein nanoparticle vaccine for eliciting anti-tumor responses.A Comparison Study of iTEP Nanoparticle-Based CTL Vaccine Carriers Revealed a Surprise Relationship between the Stability and Efficiency of the Carriers.Enhancement of anti-tumor effect of particulate vaccine delivery system by 'bacteriomimetic' CpG functionalization of poly-lactic-co-glycolic acid nanoparticlesNanomaterials in the application of tumor vaccines: advantages and disadvantages.Hybrid-Actuating Macrophage-Based Microrobots for Active Cancer Therapy.Biomimetic protein nanoparticles facilitate enhanced dendritic cell activation and cross-presentation.Tumor lysate-loaded biodegradable microparticles as cancer vaccines.Carbohydrate-based cancer vaccines: target cancer with sugar bullets.Mesoporous silica nanoparticles as antigen carriers and adjuvants for vaccine delivery.Biodegradable particles as vaccine antigen delivery systems for stimulating cellular immune responses.Availability of polymeric nanoparticles for specific enhanced and targeted drug delivery.Delivering colloidal nanoparticles to mammalian cells: a nano-bio interface perspective.Applying biodegradable particles to enhance cancer vaccine efficacy.Cancer immunotherapy: nanodelivery approaches for immune cell targeting and trackingOptimization of a Method to Prepare Liposomes Containing HER2/Neu- Derived Peptide as a Vaccine Delivery System for Breast Cancer.Multifunctional nanoparticles for cancer immunotherapy.Archaeosome: as new drug carrier for delivery of Paclitaxel to breast cancerEmerging nanotechnologies for cancer immunotherapyIs There an Optimal Formulation and Delivery Strategy for Subunit Vaccines?Application of nanomedicine for crossing the blood-brain barrier: Theranostic opportunities in multiple sclerosis.
P2860
Q26748776-58AF4F1A-42DB-45C5-9005-56C36E35C2CAQ26750929-C3644E27-BB46-4882-8754-50FA54AFABBFQ26830028-35779EA9-A0C3-42EF-9962-4FBB9509A288Q28071773-C8837E8B-B0F2-4ADB-98ED-8E313C41425FQ28083065-A799E077-4EA3-4B7F-A53C-C82A280CC899Q28085563-6D7346B5-4328-4C41-B298-F87CC238405FQ28385606-1EBB6501-D020-4992-A0D4-41559D9EB23BQ28818166-FC87C585-B4A7-4456-837F-F78237441DFFQ33815087-3D776D35-E950-4A11-84AA-8245A5A4D6DAQ34133510-DB1D2F50-E014-41A0-B5C1-E345BADAEF5EQ34139885-DAF8AEFD-5FE9-4A15-85C0-1A391792F6D8Q34808155-183D6894-960D-4DE0-9224-B5479879739CQ35007523-4170959A-FAF4-4134-8551-111D46978B3AQ35067368-4E4B9616-CAA8-46E8-9A79-A7A2F60E58B3Q35174485-82E25ACA-0323-47D2-9C8A-FC414FB8ECA4Q35753059-73892901-4B8A-45B4-B97D-714EFB3B4C55Q35763466-3017BAF2-639F-4932-9E00-B6BE8E994839Q36396099-E76E555B-F08C-4866-8497-5E0B6706A459Q36582010-08A5F80B-08F1-4591-9CD1-DDC924E1A609Q36630822-F3F0A532-C3D6-42C3-A437-581AECE8BC04Q36642808-FD49DC62-48F2-4540-8557-6181B62FC7B8Q36723754-EE64DA1C-EE0C-4058-811B-8A95EB6CC686Q36822999-FCC96B13-740F-40EE-B4AE-7C12110FC25EQ36925868-5A68EF9D-A898-4D5F-87BB-23EE5F8B005DQ37039986-F07E5937-967D-4BF0-8B3F-9457CEEA8610Q37483316-DAC9F03C-297B-4581-861D-6447BC700FC9Q37670779-AD499C64-339F-4F0A-8365-FC46D438B4DFQ38016342-96074C68-E96E-47F2-A46F-47EC851B9A3DQ38105259-3E98DC10-E1A9-4639-8C53-5190737D4BF7Q38131659-0CE3B5BD-2F34-40BB-99DC-6B73D508440BQ38151736-5D824A6E-78FF-4968-93E2-2A3C7A377893Q38180108-D6C109E4-0A48-45D2-A582-CB690AF12CB4Q38212549-C5360E32-ED9B-4B2E-9322-7E62EE8F2C06Q38288055-0DCC40AA-2674-454F-8B47-53E2CDA1F01CQ38627817-88D27441-406B-4351-9C57-535B42B9D083Q38744042-EB3225CF-375A-4F0B-AA72-97AF4F4063E2Q38815612-4EFCB68A-6923-4BEA-B8B9-BDA4DDC31CB8Q38837036-660BDCE8-6123-48B1-82DB-ED735BA75EB3Q38886698-D206C695-C16B-47F7-990B-69F1977E97C6Q38896543-8EAC7A39-A28D-4849-A704-406B03F0C6E7
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Nanoparticle delivery systems in cancer vaccines.
@ast
Nanoparticle delivery systems in cancer vaccines.
@en
type
label
Nanoparticle delivery systems in cancer vaccines.
@ast
Nanoparticle delivery systems in cancer vaccines.
@en
prefLabel
Nanoparticle delivery systems in cancer vaccines.
@ast
Nanoparticle delivery systems in cancer vaccines.
@en
P2093
P2860
P1476
Nanoparticle delivery systems in cancer vaccines
@en
P2093
Caitlin D Lemke
Sean M Geary
Yogita Krishnamachari
P2860
P304
P356
10.1007/S11095-010-0241-4
P577
2010-08-19T00:00:00Z